Healthcare cold chain logistics comprises transportation and distribution of pharmaceutical products which are temperature-sensitive. It helps the healthcare industry in several ways such as increase the shelf life of numerous medicines and ensure uninterrupted supply of equipment, medicines, and devices from suppliers & distributors to different locations.
According to study, “Healthcare Cold Chain Logistics Market Information by Product type (Biopharmaceuticals, Vaccines, Clinical Trial Materials and Others), Services (Storage, Transportation, Packaging and Others), Storage Techniques (Electrical refrigeration, Dry Ice, Gel Packs, Liquid nitrogen and Others), By Region (North America, Europe, Asia Pacific, The Middle East & Africa (MEA) and Latin America) - Global Forecast by 2023” the key companies operating in the healthcare cold chain logistics market are DB Schenker, FedEx, American Airlines, Inc., Marken, Cavalier Logistics, KUEHNE + NAGEL, DHL international GmbH, AmerisourceBergen Corporation, Agility, Biotec Services International, Air Canada Cargo, Biocair International, Avinex Ukr, Continental Air Cargo, CEVA, Igloo Thermo-Logistics, Cold Chain Technologies, L&M Transportation Services, CSafe Global, Nordic Cold Storage, Helapet, Panalpina World Transport, Kerry Logistics, LifeConEx, Kuehne + Nagel International, VersaCold, Sofrigam, World Courier Management, UTi Pharma, TNT Express.
Based on product type, healthcare cold chain logistics market is segmented into biopharmaceuticals, clinical trial materials, vaccines and others. Biopharmaceuticals are usually complex protein molecules and their efficacy requires temperature definite logistics. Vaccines segment is estimated to witness lucrative growth owing to mass immunization programs conducted by various government & non-government organizations during the forecast period. Based on services, market is segmented into storage, packaging, transportation and others. Based on mode of transportation, market is segmented into air, ground, and ocean. Based on holding temperature range, market is segmented into ambient, frozen, refrigerated, and deep frozen / cryogenic. Based on storage techniques, market is segmented into dry ice, electrical refrigeration, liquid nitrogen, gel packs, and others. Based on container type, market is segmented into active containers and passive containers. In addition, based on end-user, market is segmented into research institutes, biopharmaceutical companies, hospitals & clinics, and others.
The healthcare cold chain logistics market is driven by growth in transportation of temperature-sensitive pharmaceutical products via cold chain logistics, rise in number of clinical trials, increase in preference for personalized drugs by large patient pool, and increase in pharmaceutical sector. However, high operational cost and lack of standardization may impact the market. Moreover, growth in technological advancements in cold chain logistics is a key opportunities for market.
Recently, governmental & non-governmental organizations are focusing on providing healthcare facilities in the underdeveloped regions. Initiatives for instance mass immunization, which requires vaccines stored in the temperature-controlled chambers, in numerous developing & underdeveloped regions are generating demand for cold chain logistics for transportation of temperature-sensitive medications, leading to the growth of the global healthcare cold chain logistics market.
Based on geography, the North-American region holds major share in healthcare cold chain logistics market owing to existence of a vast pharmaceutical manufacturing sector and presence of large number of service providers in the region. The European and Asian-Pacific regions are expected to witness higher growth rate due to rapidly growth in geriatric population, various government initiatives to take corrective actions in emerging economies and growth in demand for biopharmaceutical products over the forecast period. It is projected that the market will be reached at rapid pace as a result of rise in research in the field of molecular biotechnology and widespread stem cell research during the forecast period. The market is anticipated to reach a market share of US $16,588.3 million by the year 2023.
To know more, click on the link below:-
Ankur Gupta, Head Marketing & Communications